155 related articles for article (PubMed ID: 33594432)
1. Antifungal effects of Streptococcus mutans extract on Candida strains susceptible and resistant to fluconazole: An in vivo study.
Alves MS; Fugisaki LRO; Dos Santos JD; Scorzoni L; Medina RP; Silva DHS; Junqueira JC
Med Mycol; 2021 Jul; 59(7):744-747. PubMed ID: 33594432
[TBL] [Abstract][Full Text] [Related]
2. Verapamil inhibits efflux pumps in
Vega-Chacón Y; de Albuquerque MC; Pavarina AC; Goldman GH; Mima EGO
Virulence; 2021 Dec; 12(1):231-243. PubMed ID: 33410730
[TBL] [Abstract][Full Text] [Related]
3. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
Li Y; Yang J; Li X; Su S; Chen X; Sun S; Li Y
Int J Antimicrob Agents; 2020 Aug; 56(2):106030. PubMed ID: 32454072
[TBL] [Abstract][Full Text] [Related]
4. Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.
Souza AC; Fuchs BB; Pinhati HM; Siqueira RA; Hagen F; Meis JF; Mylonakis E; Colombo AL
Antimicrob Agents Chemother; 2015 Oct; 59(10):6581-7. PubMed ID: 26259795
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Zhang M; Yan H; Lu M; Wang D; Sun S
Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
8. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
9. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
[TBL] [Abstract][Full Text] [Related]
10. Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.
Li DD; Deng L; Hu GH; Zhao LX; Hu DD; Jiang YY; Wang Y
Biol Pharm Bull; 2013; 36(9):1482-7. PubMed ID: 23995660
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
12. Synergistic potential of teriflunomide with fluconazole against resistant
Li X; Kong B; Sun Y; Sun F; Yang H; Zheng S
Front Cell Infect Microbiol; 2023; 13():1282320. PubMed ID: 38169891
[TBL] [Abstract][Full Text] [Related]
13. Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
Mannala GK; Rupp M; Walter N; Scholz KJ; Simon M; Riool M; Alt V
J Orthop Res; 2023 Nov; 41(11):2547-2559. PubMed ID: 37080929
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
15. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
[TBL] [Abstract][Full Text] [Related]
17. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Sanati H; Belanger P; Fratti R; Ghannoum M
Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
[TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans.
Jafri H; Khan MSA; Ahmad I
Phytomedicine; 2019 Feb; 54():206-213. PubMed ID: 30668370
[TBL] [Abstract][Full Text] [Related]
19. Gentamicin synergises with azoles against drug-resistant Candida albicans.
Lu M; Yu C; Cui X; Shi J; Yuan L; Sun S
Int J Antimicrob Agents; 2018 Jan; 51(1):107-114. PubMed ID: 28943366
[TBL] [Abstract][Full Text] [Related]
20. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]